13h
Hosted on MSNAI skin cancer detection app claims 99.8 per cent accuracy rate in ruling out cancerBritish tech company Skin Analytics has received regulatory approval for an AI skin cancer detection system that uses a ...
NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...
Odell Beckham Jr. (OBJ) and his dermatologist discuss his experience with seb derm, or seborrheic dermatitis, as the Wide ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Roth MKM analyst Jason Wittes maintained a Buy rating on Journey Medical Corp (DERM – Research Report) today and set a price target of $11.00.
"If your skin is extremely dry and inflamed, applying a zinc oxide–based diaper rash cream can help repair your skin barrier ...
Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...
Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, ...
Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S ...
Journey Medical Corporation’s DERM share price has surged by 14.32%, which has investors questioning if this is right time to sell.
Journey Medical Co. (NASDAQ:DERM – Get Free Report) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 76,800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results